The primary purpose of the program is to elucidate the fundamental mechanisms of maternal-fetal drug disposition in pregnant women with special emphasis on drugs of abuse, and those used in the treatment of drug abuse. Once collected, the data will be synthesized into Physiologically Based Pharmacokinetic (PBPK) models that will help predict maternal and fetal exposure to illicit and licit drugs used by pregnant women.
NIH from 2013 – 2017
Chair, Department of Pharmaceutics
Related UW Entities
School of Pharmacy: Department of Pharmaceutics, Department of Pharmacy
School of Medicine: Department of Obstetrics and Gynecology